CSI Compressco LP (CCLP) Reaches $4.27 1 Year Low; Prothena PLC Has 0.94 Sentiment

June 26, 2017 - By Peter Erickson

Prothena Corporation Public Limited Company is a global biotechnology company. The company has market cap of $2.25 billion. The Firm is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. It currently has negative earnings. The Company’s clinical pipeline of antibody product candidates targets a range of indications, including Amyloid Light-chain amyloidosis (NEOD001), Parkinson’s disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

The stock of CSI Compressco LP (NASDAQ:CCLP) hit a new 52-week low and has $4.06 target or 5.00% below today’s $4.27 share price. The 7 months bearish chart indicates high risk for the $144.01 million company. The 1-year low was reported on Jun, 26 by Barchart.com. If the $4.06 price target is reached, the company will be worth $7.20M less. About 162,157 shares traded. CSI Compressco LP (NASDAQ:CCLP) has declined 29.05% since June 26, 2016 and is downtrending. It has underperformed by 45.75% the S&P500.

Since January 1, 0001, it had 1 insider buy, and 8 sales for $3.03 million activity.

About 184,999 shares traded. Prothena Corporation PLC (PRTA) has risen 41.05% since June 26, 2016 and is uptrending. It has outperformed by 24.35% the S&P500.

Ratings analysis reveals 100% of Prothena’s analysts are positive. Out of 3 Wall Street analysts rating Prothena, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $69.0 while the high is $86.0. The stock’s average target of $76.67 is 33.80% above today’s ($57.3) share price. PRTA was included in 3 notes of analysts from December 21, 2016. The rating was initiated by Piper Jaffray on Wednesday, April 12 with “Overweight”. The stock of Prothena Corporation PLC (NASDAQ:PRTA) has “Overweight” rating given on Wednesday, April 12 by Cantor Fitzgerald. SunTrust initiated the stock with “Buy” rating in Wednesday, December 21 report.

Palo Alto Investors Llc holds 2.79% of its portfolio in Prothena Corporation PLC for 993,855 shares. Redmile Group Llc owns 653,725 shares or 2.77% of their US portfolio. Moreover, Rock Springs Capital Management Lp has 1.02% invested in the company for 309,500 shares. The Oregon-based Hood River Capital Management Llc has invested 0.77% in the stock. Oak Ridge Investments Llc, a Illinois-based fund reported 481,027 shares.

Among 5 analysts covering CSI Compressco LP (NASDAQ:CCLP), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. CSI Compressco LP has $21 highest and $10 lowest target. $11.80’s average target is 176.35% above currents $4.27 stock price. CSI Compressco LP had 10 analyst reports since July 29, 2015 according to SRatingsIntel. Janney Capital upgraded CSI Compressco LP (NASDAQ:CCLP) rating on Friday, September 23. Janney Capital has “Buy” rating and $12 target. The rating was maintained by RBC Capital Markets on Friday, August 7 with “Sector Perform”. The rating was downgraded by Raymond James on Monday, October 5 to “Outperform”. The stock of CSI Compressco LP (NASDAQ:CCLP) has “Hold” rating given on Friday, January 22 by Stifel Nicolaus. As per Wednesday, September 2, the company rating was initiated by Wells Fargo.

CSI Compressco LP is a provider of compression services and equipment for natural gas and oil production, gathering, transportation, processing and storage. The company has market cap of $144.01 million. The Firm sells custom-designed compressor packages and oilfield fluid pump systems, and provides aftermarket services and compressor package parts and components manufactured by third-party suppliers. It currently has negative earnings. It provides these compression services and equipment to a base of natural gas and oil exploration and production, midstream and transmission companies operating throughout many of the onshore producing regions of the United States, as well as in a number of foreign countries, including Mexico, Canada and Argentina.